Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6534-6540

  Makino, Yuichi ^a   Nakamura, Hiroshi ^a   Ikeda, Eiji ^b   Ohnuma, Kei ^a   Yamauchi, Kenji ^c   Yabe, Yutaka ^c   Poellinger, Lorenz ^d   Okada, Yasunori ^b   Morimoto, Chikao ^a   Tanaka, Hirotoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CD3 ANTIGEN; DNA BINDING PROTEIN; HIF 1 PROTEIN; HIF-1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; NUCLEAR PROTEIN; PEPTIDE; UNCLASSIFIED DRUG;

ACTIVATION INDUCED CELL DEATH; ANTIGEN FUNCTION; ARTICLE; AUTOCRINE EFFECT; BIOSYNTHESIS; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOSTIMULATION; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 10744233368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6534     Document Type: Article

References (46)

1. Rathmell, J. C., and C. B. Thompson. 2002. Pathways of apoptosis in lymphocyte, development, homeostasis, and disease. Cell 109:S97.
2. Van Panjs, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
3. Nagata, S. 1998. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J. Hum. Genet. 43:2.
4. Wells. A. D., X. C. Li, Y. Li, M. C. Walsh, X. X. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. W. Hancock. et al. 1999. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5:1303.
5. Camacho, I. A., M. R. Hassuneh, M. Nagarkatti, and P. S. Nagarkatti. 2001. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165:51.
6. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407, 789.
7. L. Immunity 3:87.
8. Marrack, P., J. Bender, D. Hildeman, M. Jordan, T. Mitchell, M. Murakami, A. Sakamoto, B. C. Schaefer, B. Swanson, and J. Kappler. 2000. Homeostasis of αβ TCR+ T cell. Nat. Immunol. 1:107.
9. Habler, O. P., and K. F. W. Messmer. 1997. The physiology of the oxygen transport. Transfus. Sci. 18:425.
10. Vaupel, P., O. Thews, D. K. Kelleher, and M. Hoeckel. 1998. Current status of knowledge and critical issues in tumor oxygenation: results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454:591.
11. Semenza, G. L. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell. Biol. 13:167.
12. Wenger, R. H. 2000. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203:1253.
13. Makino, Y., R. Cao, K. Svensson, G. Bertilsson, M. Asman, H. Tanaka, Y. Cao, A. Berkenstam, and L. Poellinger. 2001. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414:550.
14. Tanimoto, K., Y. Makino, T. Pereira, and L. Poellinger. 2000. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19:4298.
15. Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271.
16. Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin, Jr. 2001. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464.
17. Epstein, A. C. R., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E., Metzen, M. I. Wilson, A., Dhanda, et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43.
18. Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337.
19. Carrero, P., K. Okamoto, P. Coumailleau, S. O'Brien, H. Tanaka, and L. Poellinger. 2000. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α Mol. Cell. Biol. 20:402.
20. Ema, M., K. Hirota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, and Y. Fujii-Kuriyama. 1999. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1905.
21. Kung, A. L., S. Wang, J. M. Kleo, W. G. Kaelin, and D. M. Livingston. 2000. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat. Med. 6:1335.
22. Lando, D., D. J. Peet, D. A. Whelan, J. J. Gorman, and M. L. Whitelaw. 2002. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858.
23. Lukashev, D., C. Caldwell, A. Ohta, P. Chen, and M. Sitkovsky. 2001. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1α in activated T lymphocytes. J. Biol. Chem. 276:48754.
24. Kojima, H., H. Gu, S. Nomura, C. C. Caldwell, T. Kobata, P. Carmeliet, G. L. Semenza, and M. V. Sitkovsky. 2002. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl. Acad. Sci. USA 99:2170.
25. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Forster, R. Pawlinkski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112:645.
26. Kamitani, S., M. Asakawa, Y. Shimekake, K. Kuwasako, K. Nakahara, and T. Sakata. 1999. The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett. 448:111.
27. Wan, Y. Y., and J. DeGregori. 2003. The survival of antigen-stimulated T cells requires NFκB-mediated inhibition of p73 expression. Immunity 18:331.
28. Garayoa, M., A. Martinez, S. Lee, R. Pio, W. G. An, L. Neckers, J. Trepel, L. M. Montuenga, H. Ryan, R. Johnson, et al. 2000. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol. 14:848.
29. Oehler, M. K., C. Norbury, S. Hague, M. C. P. Rees, and R. Bicknell. 2001. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 20:2937.
30. Kim, W., S.-O. Moon, M. J. Sung, S. H. Kim, S. Lee, H. J. Kim, G. Y. Koh, and S. K. Park. 2002. Protective effect of adrenomedullin in mannnitol-induced apoptosis. Apoptosis 7:527.
31. Tokudome, T., T. Horio, F. Yoshihara, S. Suga, Y. Kawano, M. Kohno, and K. Kangawa. 2002. Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinolgy 143:3515.
32. Kato, K., H. Yin, J. Agata, H. Yoshida, L. Chao, and J. Chao. 2003. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. 285:H1506.
33. Conforti, L., M. Petrovic, D. Mohammad, S. Lee, Q. Ma, S. Barone, and A. H. Filipovich. 2003. Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J. Immunol. 170:695.
34. Wenger, R. H., A. Rolfs, P. Spielmann, D. R. Zimmermann, and M. Gassmann. 1998. Mouse hypoxia-inducible factor-1α is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91:3471.
35. Talks, K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, and A. L. Harris. 2000. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157:411.
36. Burke, B., N. Tang, K. P. Corke, D. Tazzyman, K. Ameri, M. Wells, and C. E. Lewis. 2002. Expression of HIF-1α by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196:204.
37. Lee, S. H., P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite. 2000. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342:626.
38. Royer, C., J. Lachuer, G. Crouzoulon, J. Roux, J. Peyronnet, J. Mamet, J. Pequignot, and Y. Dalmaz. 2000. Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain. Brain Res. 856:119.
39. Shapiro, L., and C. A. Dinarello. 1995. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. USA 92:12230.
40. Rosenspire, A. J., A. L. Kindzelskii, and H. R. Petty. 2002. Fever-associated temperatures enhance neutrophil responses to lipopolysaccharide: a potential mechanism involving cell metabolism. J. Immunol. 169:5396.
41. Ostberg, J. R., C. Gellin, R. Patel, and E. A. Repasky. 2001. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J. Immunol. 167:2666.
42. Perregaux, D. G., R. E. Laliberte, and C. A. Gabel. 1996. Human monocyte interleukin-1β posttranslational processing. J. Biol. Chem. 271:29830.
43. Naldini, A., F. Carraro, S. Silvestri, and V. Bocci. 1997. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J. Cell. Physiol. 173:335.
44. Grimshaw, M. J., and F. R. Balkwill. 2001. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation-a potential mechanism. Eur. J. Immunol. 31:480.
45. Loeffler, D. A., P. C. Keng, R. B. Baggs, and E. M. Lord. 1990. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor. Int. J. Cancer 45:462.
46. Caldwell, C. C., H. Kojima, D. Lukashev, J. Armstrong, M. Farber, S. G. Apasov, and M. V. Sitkovsky. 2001. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167:6140.